Skip to main content

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Mireia Caralt Barba

Mireia Caralt Barba

Senior researcher
General Surgery
Read more
Tomàs Pumarola Suñé

Tomàs Pumarola Suñé

Main researcher
Microbiology
Read more
Mercè Beltran Vilagrasa

Mercè Beltran Vilagrasa

Cap d'Unitat
Internal Strategy Directorate
Read more
Marc Ribó Jacobi

Marc Ribó Jacobi

Main researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.